A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less ...

“Taking these medications puts individuals at risk of everything from allergic reactions to uncontrolled blood sugar levels, ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

Patients taking Novo Nordisk’s Wegovy plus Veru’s enobosarm saw 71% lower lean mass loss than those who were taking Wegovy ...

Novo Nordisk said patients taking a bigger dose of its blockbuster obesity drug lost more weight than those on a lower dose, ...

A new study conducted by researchers from the University of Eastern Finland the Karolinska Institutet explored the ways that ...

Children who lost enough weight to no longer be considered obese had similar reductions in risk, and also experienced a 60% ...

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...

The number of Netherlands residents using medicines like Ozempic, Wegovy, and Mounjaro for weight loss is increasing ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...